Propoxyphene-induced torsades de pointes

被引：10
|
作者：
Adler, Arnon [1 ,2 ]
Viskin, Sami [1 ,2 ]
Bhuiyan, Zahir A. [3 ]
Eisenberg, Elon [4 ]
Rosso, Raphael [1 ,2 ]
机构：
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[3] CHU Vaudois, Serv Genet Med, Genet Mol Lab, CH-1011 Lausanne, Switzerland
[4] Technion Israel Inst Technol, Inst Pain Med, Haifa, Israel
来源：
HEART RHYTHM | 2011年 / 8卷 / 12期
关键词：
LONG QT SYNDROME; HERG CHANNEL; METHADONE; PROLONGATION; KCNE1; FLUOXETINE; INTERVAL; RISK; D85N; LEVOMETHADYL;
D O I：
10.1016/j.hrthm.2011.07.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1952 / 1954
页数：3
相关论文
共 50 条
  • [31] The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes
    Behr, Elijah R.
    January, Craig
    Schulze-Bahr, Eric
    Grace, Andrew A.
    Kaeaeb, Stefan
    Fiszman, Monica
    Gathers, Shaniece
    Buckman, ShaAvhree
    Youssef, Ashraf
    Pirmohamed, Munir
    Roden, Dan
    EUROPEAN HEART JOURNAL, 2013, 34 (26) : 1958 - 1963
  • [32] Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block
    Cho, Min Soo
    Nam, Gi-Byoung
    Kim, Yong-Guin
    Hwang, Ki-Won
    Kim, Yoo Ri
    Choi, HyungOh
    Kim, Sung-Hwan
    Rhee, Kyoung-Suk
    Kim, Nam-Joon
    Kim, June Soo
    Kim, Jun
    Choi, Kee-Joon
    Kim, You-Ho
    HEART RHYTHM, 2015, 12 (03) : 498 - 505
  • [33] PARP inhibitor-induced torsades de pointes in long QT syndrome: a case report
    Segan, Louise
    Beekman, Ashley
    Parfrey, Shane
    Perrin, Mark
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2020, 4 (01)
  • [34] Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes
    Jason Levi Esses
    Jonathan Rosman
    Lien Thanh Do
    Paul Schweitzer
    Sam Hanon
    Journal of Interventional Cardiac Electrophysiology, 2008, 23 : 117 - 119
  • [35] Predicting the Unpredictable Drug-Induced QT Prolongation and Torsades de Pointes
    Schwartz, Peter J.
    Woosley, Raymond L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1639 - 1650
  • [36] Phenytoin in Treatment of Methadone-Induced Torsades de Pointes: A Case Report
    Altheeb, Zaid
    Alziadat, Moayyad
    Shamoon, Fayez
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E634 - E636
  • [37] Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes
    Esses, Jason Levi
    Rosman, Jonathan
    Do, Lien Thanh
    Schweitzer, Paul
    Hanon, Sam
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2008, 23 (02) : 117 - 119
  • [38] Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient
    Nair, Murali K.
    Patel, Krunal
    Starer, Perry J.
    ADDICTION, 2008, 103 (12) : 2062 - 2064
  • [39] The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis
    Abrich, Victor A.
    Ramakrishna, Harish
    Mehta, Arjun
    Mookadam, Farouk
    Srivathsan, Komandoor
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 232 : 243 - 246
  • [40] Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)
    Poluzzi, Elisabetta
    Raschi, Emanuel
    Moretti, Ugo
    De Ponti, Fabrizio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (06) : 512 - 518
12345